BenzingaBenzinga

Chubb's Growth Slows Vs. Peers, Analyst Downgrades Despite Stock Surge

BofA Securities analyst Joshua Shanker downgraded Chubb Limited CB to Underperform from Neutral, while raising the price target to $275 from $264.

The analyst downgraded the stock after a period of strong outperformance (up 29% YTD and 41% over the past year) in CB shares and the broader P&C sector.

The analyst writes that over the past decade, Chubb’s book value per share (BVPS), tangible BVPS, and EPS grew at CAGRs of 7%, 5%, and 10%, respectively—lower than peers despite a premium valuation.

Although growth accelerated to 15%, 17%, and 14% over the last year, it still lagged behind peers as P&C underwriting margins peaked, adds the analyst.

Shanker says the company’s slower growth stems from lower operating leverage, a focus on premium-to-book acquisitions, and less efficient share repurchases at higher valuations.

The analyst’s 2025 forecast of 6% EPS growth and 12% BVPS growth is below consensus and at the lower end of peer expectations, with some peers poised for 20%+ BVPS growth.

Notably, the analyst’s estimates for 2025 and 2026 EPS forecasts dip slightly due to higher share prices for repurchases following stock outperformance.

However, Shanker’s third-quarter EPS estimate rose by nearly $0.20 per share as they lowered expectations for catastrophe losses.

The analyst projects third-quarter catastrophe activity at 7.7% of Global P&C earned premiums, below the typical 9%, with no major events.

Investors can gain exposure to the stock via iShares U.S. Insurance ETF IAK and Invesco KBW Property & Casualty Insurance ETF KBWP.

Price Action: CB shares are up 0.52% at $290.05 at the last check Friday.

Photo via Shutterstock

Read Next:

Latest Ratings for CB

DateFirmActionFromTo
Feb 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022Raymond JamesMaintainsStrong Buy
Jan 2022Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for CB

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Baca artikel penuh
Dapatkan akses tanpa had kepada artikel dari Benzinga dan semua sumber berita di TradingView.